Biotechnology and Bioengineering
ARTICLE

3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes

Cláudia Correia

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Alexey Koshkin

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Patrícia Duarte

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Dongjian Hu

Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts

Harvard Medical School, Boston, Massachusetts

Harvard Stem Cell Institute, Cambridge, Massachusetts

Search for more papers by this author
Madalena Carido

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Maria J. Sebastião

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Patrícia Gomes‐Alves

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
David A. Elliott

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Australia

Search for more papers by this author
Ibrahim J. Domian

Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts

Harvard Medical School, Boston, Massachusetts

Harvard Stem Cell Institute, Cambridge, Massachusetts

Search for more papers by this author
Ana P. Teixeira

Corresponding Author

E-mail address: anat@ibet.pt

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Correspondence

Margarida Serra and Ana P. Teixeira, Animal Cell Technology Unit, iBET, Instituto de Biologia Experimental e Tecnológica and Instituto de Tecnologia Química e Biológica, Apartado 12, 2781–901 Oeiras, Portugal.

Email: mserra@ibet.pt (M.S); anat@ibet.pt (A.P.T)

Search for more papers by this author
Paula M. Alves

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Search for more papers by this author
Margarida Serra

Corresponding Author

E-mail address: mserra@ibet.pt

iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal

Correspondence

Margarida Serra and Ana P. Teixeira, Animal Cell Technology Unit, iBET, Instituto de Biologia Experimental e Tecnológica and Instituto de Tecnologia Química e Biológica, Apartado 12, 2781–901 Oeiras, Portugal.

Email: mserra@ibet.pt (M.S); anat@ibet.pt (A.P.T)

Search for more papers by this author
First published: 27 November 2017
Citations: 25
Present address of Ana P. Teixeira is ETH Zurich, Department of Biosystems Science and Engineering, Mattenstrasse 26, 4058 Basel, Switzerland.
Get access to the full version of this article. View access options below.

Log in with Open Athens, Shibboleth, or your institutional credentials.

If you have previously obtained access with your personal account, .

    • View the article PDF and any associated supplements and figures for a period of 48 hours.
    • Article can not be printed.
    • Article can not be downloaded.
    • Article can not be redistributed.
    • Unlimited viewing of the article PDF and any associated supplements and figures.
    • Article can not be printed.
    • Article can not be downloaded.
    • Article can not be redistributed.
    • Unlimited viewing of the article/chapter PDF and any associated supplements and figures.
    • Article/chapter can be printed.
    • Article/chapter can be downloaded.
    • Article/chapter can not be redistributed.

Abstract

Three‐dimensional (3D) cultures of human pluripotent stem cell derived cardiomyocytes (hPSC‐CMs) hold great promise for drug discovery, providing a better approximation to the in vivo physiology over standard two‐dimensional (2D) monolayer cultures. However, the transition of CM differentiation protocols from 2D to 3D cultures is not straightforward. In this work, we relied on the aggregation of hPSC‐derived cardiac progenitors and their culture under agitated conditions to generate highly pure cardiomyocyte aggregates. Whole‐transcriptome analysis and 13C‐metabolic flux analysis allowed to demonstrate at both molecular and fluxome levels that such 3D culture environment enhances metabolic maturation of hiPSC‐CMs. When compared to 2D, 3D cultures of hiPSC‐CMs displayed down‐regulation of genes involved in glycolysis and lipid biosynthesis and increased expression of genes involved in OXPHOS. Accordingly, 3D cultures of hiPSC‐CMs had lower fluxes through glycolysis and fatty acid synthesis and increased TCA‐cycle activity. Importantly, we demonstrated that the 3D culture environment reproducibly improved both CM purity and metabolic maturation across different hPSC lines, thereby providing a robust strategy to derive enriched hPSC‐CMs with metabolic features closer to that of adult CMs.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.